Activation of PI-3 kinase signaling pathways in gliomas leads to the activation of downstream effector molecules such as Akt and mTOR (the mammalian target of rapamycin), which promote proliferation and resistance to apoptosis [44]. The gene discussed is MTOR; the disease is central nervous system cancer.